Exploration and Practice of Introducing the Pharmaceutical Care Network Europe Classification System to Psychiatric Drugs
Journal of Pharmacy Practice · 2025
DOI: 10.1177/08971900241273200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy Practice, 2025. Verfasst von Menglan Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shanghai Mental Health Center, Shanghai, PR China. Hauptthemen laut MEDLINE: Psychotropic Drugs, Drug-Related Side Effects and Adverse Reactions. Die Arbeit nennt 28 Literaturangaben. Gefördert von: The foundation of Shanghai mental health center.
Abstract (Originalsprache)
This research aims to summarize and discuss issues related to psychiatric drugs by using the classification system of the Pharmaceutical Care Network Europe (PCNE) and to provide a reference for the development and direction of clinical pharmacists’ work in the future. Psychiatric patients who were hospitalized in our hospital from Janurary 2023 to December 2023 were enrolled. Drug-related problems (DRPs) were evaluated using the PCNE classification system (version 9.0). The types, causes, intervention plans, acceptance of intervention plans, and statuses of DRPs were analyzed. A total of 362 patients were included, covering 405 DRP cases, with an average DRP of 1.12 for each patient. All 405 DRP cases underwent interventions, with a success rate of 83.46%. The main categories of related drugs were psychotropic drugs (70.37%), anti-infective drugs (8.89%), and cardiovascular system drugs (5.19%). The main DRPs were possible adverse drug events (21.24%), poor treatment effects (69.14%), and unnecessary medication treatment (9.63%). The main causes of DRPs were inappropriate drug selection (18.52%), inappropriate combinations of drugs (16.05%), and excessive drug dosage (13.58%). The PCNE classification system helps clinical pharmacists improve their ability to identify and solve DRPs faced by psychiatric departments, improve pharmaceutical care efficiency, and ensure rational drug use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Shanghai Mental Health Center, Shanghai, PR China.
ORCID-Profile: Menglan Shi
Förderung
- The foundation of Shanghai mental health center
Zitieren
APA
Shi, M., Ma, Y., Li, H., Li, F., & Shen, S. (2025). Exploration and Practice of Introducing the Pharmaceutical Care Network Europe Classification System to Psychiatric Drugs. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900241273200
Vancouver
Shi M, Ma Y, Li H, Li F, Shen S. Exploration and Practice of Introducing the Pharmaceutical Care Network Europe Classification System to Psychiatric Drugs. Journal of Pharmacy Practice. 2025. doi:10.1177/08971900241273200
BibTeX
@article{Shi2025,
author = {Shi, Menglan and Ma, Yan and Li, Hong and Li, Fangjie and Shen, Shujuan},
title = {Exploration and Practice of Introducing the Pharmaceutical Care Network Europe Classification System to Psychiatric Drugs},
journal = {Journal of Pharmacy Practice},
year = {2025},
doi = {10.1177/08971900241273200}
}
EUVIMED